NEW! Bi-monthly transfection eNewsletter

Browse our databases for further information on:

6000+ Publications on Amaxa™ Nucleofector™ Technology for Hard-to-Transfect Cells

 

  • Non-viral transfection technology
  • Up to 95% transfection efficiency for primary cells, stem cells and hard-to-transfect cell lines
  • More than 700 different cell types successfully transfected
  • Maintenance of cell functionality
  • Expert scientific support at your fingertips
  • Reliable technology made in Germany

 

Number of peer-reviewed publications (cumulative)

transfection publications

Developed in 1998, Nucleofection™ has evolved through continuous innovation into a comprehensive portfolio of devices and kits for many different transfection needs. 
 

Our Cells on Demand Transfection Services is available for those missing the resources or expertise to do transfection in their lab.


Nucleofection™ Accessories